Results 301 to 310 of about 399,723 (373)

Isoquercetin and Zafirlukast Cooperatively Suppress Tumor Growth and Thromboinflammatory Signaling in a Xenograft Model of Ovarian Cancer

open access: yesThe FASEB Journal, Volume 40, Issue 1, 15 January 2026.
Treatment using either the thiol isomerase inhibitor isoquercetin or zafirlukast lowers tissue factor levels, decreases VEGF, inhibits PD‐L1, and TMEM176B in a xenograft model of ovarian cancer. A combination of the two agents, at threefold lower concentrations than either drug, significantly enhanced the inhibition further, suggesting a dual action of
Justine A. Keovilay   +4 more
wiley   +1 more source

[The levels of plasminogen and inhibitor of plasminogen activators of type 1 in antiphospholipid syndrome].

open access: green, 2012
E. V. Ostryakova   +10 more
openalex   +1 more source

Impact of Plasminogen Activator Inhibitor-1 Serum Levels and the -675 4G/5G Variant in the SERPINE1 Gene on Systemic Sclerosis in a Mexican Population. [PDF]

open access: yesLife (Basel)
Lomelí-Nieto JA   +10 more
europepmc   +1 more source

Epithelial glycoprotein-330 mediates endocytosis of plasminogen activator-plasminogen activator inhibitor type-1 complexes

open access: hybrid, 1993
Søren K. Moestrup   +7 more
openalex   +1 more source

Hemi‐Orolingual Angioedema in a Patient With VEXAS Syndrome

open access: yes
eJHaem, Volume 7, Issue 1, February 2026.
Edwin U. Suárez   +2 more
wiley   +1 more source

Increased plasminogen activator inhibitor-1 (PAI-1) and its associations with metabolic risk in healthy young adults with early life stress. [PDF]

open access: yesPsychoneuroendocrinology
Kudinova AY   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy